Gene · 9760
Papers2,030
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,030
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Aryl Hydrocarbon Receptor (AHR) Suppresses Arsenic (As3+)-Induced Malignant Transformation by Antagonizing TOX Expression. | Int J Biol Sci | 2025 | 40303305 | PubTator, text mining | PubMed |
| Altered volume of thalamic nuclei and genetic expression in first-episode psychotic patients, and their association with childhood adversity. | Prog Neuropsychopharmacol Biol Psychiatry | 2025 | 40250785 | PubTator, text mining | PubMed |
| Dual STAT3/STAT5 inhibition as a novel treatment strategy in T-prolymphocytic leukemia. | Leukemia | 2025 | 40234614 | PubTator, text mining | PubMed |
| Combination radiation and αPD-L1 enhance tumor control by stimulating CD8+ PD-1+ TCF-1+ T cells in the tumor-draining lymph node. | Nat Commun | 2025 | 40229241 | PubTator, text mining | PubMed |
| IL-15 Complex Enhances Agonistic Anti-CD40 + Anti-PDL1 by Correcting the T-bet to Tox Ratio in CD8+ T cells Infiltrating Pancreatic Ductal Adenocarcinoma. | Cancer Immunol Res | 2025 | 40072469 | PubTator, text mining | PubMed |
| Continuous expression of TOX safeguards exhausted CD8 T cell epigenetic fate. | Sci Immunol | 2025 | 40053604 | PubTator, text mining | PubMed |
| IDO1 inhibition enhances CLDN18.2-CAR-T cell therapy in gastrointestinal cancers by overcoming kynurenine-mediated metabolic suppression in the tumor microenvironment. | J Transl Med | 2025 | 40045363 | PubTator, text mining | PubMed |
| Clonal relationships between Tph and Tfh cells in patients with SLE and in murine lupus. | bioRxiv | 2025 | 39974998 | PubTator, text mining | PubMed |
| KLF2 maintains lineage fidelity and suppresses CD8 T cell exhaustion during acute LCMV infection. | Science | 2025 | 39946463 | PubTator, text mining | PubMed |
| TIGIT expression in extrahepatic cholangiocarcinoma and its impact on CD8 + T cell exhaustion: implications for immunotherapy. | Cell Death Dis | 2025 | 39939322 | PubTator, text mining | PubMed |
| Anti-CTLA-4 generates greater memory response than anti-PD-1 via TCF-1. | Proc Natl Acad Sci U S A | 2025 | 39786926 | PubTator, text mining | PubMed |
| Low expression of TOX predicts poor prognosis of patients with breast cancer in the real world: A retrospective study. | Heliyon | 2025 | 39758401 | PubTator, text mining | PubMed |
| TOX Does Not Drive Sepsis-Induced T-Cell Exhaustion. | Eur J Immunol | 2025 | 39676393 | PubTator, text mining | PubMed |
| Inhibition of TOX exerts anti-tumor effects in acute myeloid leukemia by upregulating IRF7 expression. | Eur J Pharmacol | 2025 | 39615865 | PubTator, text mining | PubMed |
| Methylmalonic acid induces metabolic abnormalities and exhaustion in CD8+ T cells to suppress anti-tumor immunity. | Oncogene | 2025 | 39472497 | PubTator, text mining | PubMed |
| Associations of genetic variants for refractive error and axial length in adults with ocular endophenotypes in children: a cross-sectional and longitudinal study. | Br J Ophthalmol | 2025 | 39326895 | PubTator, text mining | PubMed |
| Ag-driven CD8 + T cell clonal expansion is a prominent feature of MASH in humans and mice. | Hepatology | 2025 | 39047085 | PubTator, text mining | PubMed |
| SLAMF7 defines subsets of human effector CD8 T cells. | Sci Rep | 2024 | 39730488 | PubTator, text mining | PubMed |
| IDclust: Iterative clustering for unsupervised identification of cell types with single cell transcriptomics and epigenomics. | NAR Genom Bioinform | 2024 | 39703425 | PubTator, text mining | PubMed |
| Machine learning-based diagnostic model of lymphatics-associated genes for new therapeutic target analysis in intervertebral disc degeneration. | Front Immunol | 2024 | 39697339 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9760/papers?page=10